Baruah Paramita, Hanvey Kate, Irving Richard, Tzifa Konstance
Birmingham Children's Hospital, Birmingham, United Kingdom.
Otol Neurotol. 2017 Jun;38(5):672-677. doi: 10.1097/MAO.0000000000001372.
Analyze the presentation and evolution of chronic suppurative otitis media (CSOM) in children with cochlear implants (CI) and explore the merit of early intervention.
Retrospective patient review.
Tertiary referral hospital and cochlear implant programme.
Children with a CI who developed CSOM.
Tympanoplasty.
Disease control, recurrence of cholesteatoma, cochlear implant preservation.
Eight children fit our inclusion criteria with a mean follow up of 8 years. Onset of CSOM symptoms was observed on an average of 5 years after implantation (range, 2-13 yr) and led to surgical intervention in an average of 15.6 months following symptom onset. Cholesteatoma was found in four of the eight patients. Of these, one patient underwent a subtotal petrosectomy and explantation with reimplantation at the same stage but the reimplant failed to function and was explanted subsequently. One patient was initially managed by a canal wall up mastoidectomy and explantation but went on to require subtotal petrosectomy and labyrinthectomy for recurrent disease. One patient underwent a subtotal petrosectomy with explantation and is awaiting a reimplantation. The fourth patient had limited disease around the electrodes that was excised without compromising the implant. In the group of patients with CSOM without cholesteatoma, one underwent an explantation due to recurrent ear infections and a subsequent cartilage tympanoplasty for a retracted eardrum. The remaining three patients underwent successful excision of retraction pockets and repair of eardrums using cartilage with the implant in situ. A mean follow up of 2 years after the implant preservation surgeries shows good functioning of the CI.
Early recognition of CSOM is paramount in patients with CI as delay in treatment can result in the infection spreading via the cochleostomy resulting in loss of the cochlea. Recurrent ear infections in an implanted ear should prompt early examination to exclude the presence of middle ear disease, which may require anesthesia in a young child.
分析人工耳蜗植入(CI)儿童慢性化脓性中耳炎(CSOM)的表现及演变过程,并探讨早期干预的价值。
回顾性病例分析。
三级转诊医院及人工耳蜗植入项目。
发生CSOM的人工耳蜗植入儿童。
鼓室成形术。
疾病控制情况、胆脂瘤复发情况、人工耳蜗的保留情况。
8名儿童符合纳入标准,平均随访8年。CSOM症状平均在植入后5年出现(范围为2至13年),症状出现后平均15.6个月进行手术干预。8名患者中有4名发现胆脂瘤。其中,1例患者同期接受了岩骨次全切除术、人工耳蜗取出术及重新植入术,但重新植入的人工耳蜗未能发挥功能,随后被取出。1例患者最初接受了开放式乳突根治术及人工耳蜗取出术,但因疾病复发,继而需要接受岩骨次全切除术及迷路切除术。1例患者接受了岩骨次全切除术及人工耳蜗取出术,正在等待重新植入。第4例患者电极周围病变局限,切除病变时未影响人工耳蜗。在无胆脂瘤的CSOM患者组中,1例因反复耳部感染接受了人工耳蜗取出术,随后因鼓膜内陷接受了软骨鼓室成形术。其余3例患者在人工耳蜗原位的情况下,成功切除内陷袋并使用软骨修复鼓膜。人工耳蜗保留手术后平均随访2年显示人工耳蜗功能良好。
对于人工耳蜗植入患者,早期识别CSOM至关重要,因为治疗延迟可能导致感染通过蜗窗扩散,从而导致耳蜗丧失。植入耳反复出现耳部感染应促使早期检查以排除中耳疾病,这可能需要对幼儿进行麻醉。